Exploring pathological link between antimicrobial and amyloid peptides

Y Tang, Y Zhang, D Zhang, Y Liu, R Nussinov… - Chemical Society …, 2024 - pubs.rsc.org
Amyloid peptides (AMYs) and antimicrobial peptides (AMPs) are considered as the two
distinct families of peptides, characterized by their unique sequences, structures, biological …

Design principles and fundamental understanding of biosensors for amyloid-β detection

Y Zhang, B Ren, D Zhang, Y Liu, M Zhang… - Journal of Materials …, 2020 - pubs.rsc.org
Alzheimer's disease (AD), as an age-related, progressive neurodegenerative disease,
poses substantial challenges and burdens on public health and disease research. While …

Tetrameric Aβ40 and Aβ42 β-barrel structures by extensive atomistic simulations. II. In aqueous solution

PH Nguyen, JM Campanera, ST Ngo… - The Journal of …, 2019 - ACS Publications
Alzheimer's disease (AD) is characterized by the accumulation of extracellular Aβ42 and
Aβ40 oligomers and plaques. In a recent computational study, we found that the presence of …

Tanshinones inhibit hIAPP aggregation, disaggregate preformed hIAPP fibrils, and protect cultured cells

B Ren, Y Liu, Y Zhang, M Zhang, Y Sun… - Journal of Materials …, 2018 - pubs.rsc.org
Misfolding and aggregation of amyloid peptides are the key pathological events in many
neurodegenerative diseases. The development of effective inhibitors and drugs to prevent …

Interactions between curcumin derivatives and amyloid-β fibrils: insights from molecular dynamics simulations

JM Jakubowski, AA Orr, DA Le… - Journal of chemical …, 2019 - ACS Publications
The aggregation of amyloid-β (Aβ) peptides into senile plaques is a hallmark of Alzheimer's
disease (AD) and is hypothesized to be the primary cause of AD related neurodegeneration …

Nanotechnological approaches for targeting amyloid-β aggregation with potential for neurodegenerative disease therapy and diagnosis

R Shukla, A Singh, M Handa, SJS Flora… - Drug Discovery …, 2021 - Elsevier
Neurodegenerative disorders can arise as a result of amyloid-β production and misfolding of
its protein. The complex anatomy of the brain and the unresolved mechanics of the central …

Introduction and fundamentals of human islet amyloid polypeptide inhibitors

Y Tang, D Zhang, Y Zhang, Y Liu, X Gong… - ACS Applied Bio …, 2020 - ACS Publications
Type 2 diabetes (T2D) is a common protein misfolding disease (PMD), and its pathogenesis
is considered to be tightly associated with the aggregation of the disease-causative hIAPP …

Inhibition of amyloid oligomerization into different supramolecular architectures by small molecules: mechanistic insights and design rules

S Brahmachari, A Paul, D Segal… - Future medicinal …, 2017 - Taylor & Francis
Protein misfolding and aggregation have been associated with several human disorders,
including Alzheimer's, Parkinson's and Huntington's diseases, as well as senile systemic …

Targeting human islet amyloid polypeptide aggregation and toxicity in type 2 diabetes: An overview of peptide-based inhibitors

RK Saini, D Goyal, B Goyal - Chemical Research in Toxicology, 2020 - ACS Publications
Type 2 diabetes (T2D) is a chronic metabolic disease characterized by insulin resistance
and a progressive loss of pancreatic islet β-cell mass, which leads to insufficient secretion of …

[HTML][HTML] Atomistic-level study of the interactions between hIAPP protofibrils and membranes: Influence of pH and lipid composition

Z Qian, Y Zou, Q Zhang, P Chen, B Ma, G Wei… - … et Biophysica Acta (BBA …, 2018 - Elsevier
The pathology of type 2 diabetes mellitus is associated with the aggregation of human islet
amyloid polypeptide (hIAPP) and aggregation-mediated membrane disruption. The …